Talphera (TLPH) Depreciation and Depletion (2021 - 2022)

Talphera (TLPH) recorded quarterly Depreciation and Depletion of $100000.0 in Q4 2022, down 50.0% quarter-over-quarter from $200000.0 in Q3 2022, and down 66.67% on a YoY basis from $300000.0 in Q4 2021.

Talphera (TLPH) Depreciation and Depletion (2021 - 2022) Analysis & Trends

Talphera's Depreciation and Depletion history runs 2 years deep, the most recent figure standing at $100000.0 for Q4 2022.

  • In Q4 2022, Depreciation and Depletion fell 66.67% year-over-year to $100000.0; the TTM figure through Dec 2022 stood at $800000.0 (changed N/A YoY), while the FY2022 annual figure was $800000.0, down 27.27% from the prior year.
  • Depreciation and Depletion was $100000.0 for Q4 2022 at Talphera, down from $200000.0 in the prior quarter.
  • In the past five years, Depreciation and Depletion ranged from a high of $300000.0 in Q2 2021 to a low of $100000.0 in Q4 2022.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Depreciation and Depletion (Qtr)
1 Teva Pharmaceutical Industries 39.72 Bn 35.98 Bn 1.97 Bn 36.00 Mn
2 Zoetis 34.61 Bn 32.67 Bn 1.62 Bn -
3 United Therapeutics 24.07 Bn 21.91 Bn 648.10 Mn 21.60 Mn
4 Aurora Cannabis 16.98 Bn 16.91 Bn 33.43 Mn -
5 Neurocrine Biosciences 16.64 Bn 15.32 Bn 800.70 Mn 7.20 Mn
6 Elanco Animal Health 12.19 Bn 11.76 Bn 785.00 Mn 28.00 Mn
7 Alkermes 7.37 Bn 6.86 Bn -116.06 Mn -
8 Hims & Hers Health 6.62 Bn 5.87 Bn 396.79 Mn -
9 Lantheus Holdings 6.47 Bn 5.97 Bn 230.92 Mn -
10 Talphera 56.42 Mn 56.42 Mn - -

Historic Data

Download Data
DateValue
Dec 31, 2022 100,000.00
Dec 31, 2022 100,000.00
Sep 30, 2022 200,000.00
Sep 30, 2022 200,000.00
Jun 30, 2022 200,000.00
Jun 30, 2022 200,000.00
Dec 31, 2021 300,000.00
Dec 31, 2021 300,000.00
Sep 30, 2021 300,000.00
Sep 30, 2021 300,000.00
Jun 30, 2021 300,000.00
Jun 30, 2021 300,000.00